OTC:CERO | Income Statement | CERO THERAPEUTICS HOLDINGS, INC.

Complete source-backed income-statement history.

Available history
2021-09-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.74M$3.85M-$3.85M$2.82M-$1.03M-$0.70-$0.7042,175,02042,175,020
2026-03-31$2.34M$4.85M-$4.85M-$1.04M-$5.89M-$0.20-$0.2028,755,07328,755,073
2025-12-31-$4.54M
2025-09-30$2.39M$4.36M-$4.36M-$493,816.00-$4.86M-$9.10-$9.101,264,8841,264,884
2025-06-30$2.75M$4.72M-$4.72M-$693,524.00-$5.42M-$61.71-$61.71488,076488,076
2025-03-31$2.91M$4.95M-$4.95M-$155,400.00-$5.11M-$31.82-$31.82171,381171,381
2024-09-30$1.77M$4.4M-$4.4M$174,271.00-$4.23M-$170.22-$170.2224,83824,838
2024-06-30$2.71M$5.15M-$5.15M$2.7M-$2.45M-$302.32-$302.328,0998,099
2023-12-31-$5.11M-$258,350.00$24,410.00-$5.04M
2023-09-30-$429,801.00-$308,277.00$25,751.00-$334,028.00
2023-06-30$1.19M$2.41M-$2.41M$321,239.00-$1.39M$44,658.00-$2.09M-$0.23-$0.239,063,3779,063,377
2023-03-31$1.8M$2.44M-$2.44M$16.00-$2.44M-$0.27-$0.279,059,7329,059,732
2022-12-31$1.29M-$1.29M$276,023.00$538,698.00-$262,675.00
2022-09-30$836,685.00-$836,685.00$144,966.00$60,461.00$84,505.00
2022-06-30$376,580.00-$376,580.00-$111,569.00-$111,569.00
2022-03-31$404,777.00-$377,997.00
2021-09-30$1,000.00-$1,000.00$0.00-$1,000.004,086,250

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31-$19.92M-$19.92M
2023-12-31$5.29M$7.68M-$7.68M$385,472.00-$2.44M$94,819.00-$7.29M-$1,248.64-$1,248.645,8385,838
2022-12-31$2.91M-$2.91M-$68,577.00$599,159.00-$667,736.00